The microarray technology: facts and controversies

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
P.-Y. Lévy  Clinical Microbiology and Infection 
R. Cavallo  Clinical Microbiology and Infection 
Rapid streptococcal testing for sore throat and antibiotic resistance
L. Boyanova  Clinical Microbiology and Infection 
Rapid and sensitive diagnosis of Toxoplasma gondii infections by PCR
Gut bacterial microbiota and obesity
Migrant health—a cause for concern?
Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis  G. Choudhury,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Candida glabrata fungaemia in intensive care units
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Virological tools to diagnose and monitor hepatitis C virus infection
O. Clerc, G. Greub  Clinical Microbiology and Infection 
G. Zhao, H. Zhai, Q. Yuan, S. Sun, T. Liu, L. Xie 
R. Cantón  Clinical Microbiology and Infection 
Genital Chlamydia trachomatis infections
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Non-antibiotic strategies for sepsis
Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit  K. Thorburn,
Evaluation of viral co-infections in hospitalized and non-hospitalized children with respiratory infections using microarrays  S. Kouni, P. Karakitsos,
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Vector control: a cornerstone in the malaria elimination campaign
Training for the infectious diseases speciality in Norway
Detection of human metapneumovirus and respiratory syncytial virus by duplex real-time RT-PCR assay in comparison with direct fluorescent assay  P. Jokela,
Improvement of RNA purification from infected tissues to explore the in vivo host– pathogen interactions with microarrays  Q. Leroy, C. Rovery, D. Raoult,
B. Gordts  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
CMI editorial report 2011 Clinical Microbiology and Infection
Elements of design: the knowledge on which we build
Levofloxacin in the treatment of ventilator-associated pneumonia
Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose  P. Savard, T.M. Perl  Clinical Microbiology.
Metagenomics and probiotics
Laboratory diagnosis of Clostridium difficile disease
The practice of travel medicine in Europe
T.M. File  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Abstracts cont. Clinical Microbiology and Infection
A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures  A. Makristathis, S. Riss, A.M. Hirschl 
R. Slinger, I. Moldovan, N. Barrowman, F. Chan 
Current experience in treating invasive zygomycosis with posaconazole
Antimicrobial drug development – the past, the present, and the future
F. Ceccherini-Silberstein, V. Cento, V. Calvez, C.-F. Perno 
Statin use and clinical outcomes among pneumonia patients
Intrapartum Group B streptococcus detection by rapid polymerase chain reaction assay for the prevention of neonatal sepsis  B. Martinez de Tejada, R.E.
Listeriosis: a resurgent foodborne infection
O. Clerc, G. Greub  Clinical Microbiology and Infection 
Overview of cefixime use in community-acquired infections
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
F.J. Pastor, J. Guarro  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
B.A. Cunha  Clinical Microbiology and Infection 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Three years experience of real-time PCR for the diagnosis of Q fever
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

The microarray technology: facts and controversies N. Lěvěque, F. Renois, L. Andréoletti  Clinical Microbiology and Infection  Volume 19, Issue 1, Pages 10-14 (January 2013) DOI: 10.1111/1469-0691.12024 Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Place of microarray technology in virology laboratories: (A) After rapid antigen tests (RATs) and monoplex (RT)-PCR assays; (B) directly after RATs; (C) as first-line tests for the detection of viral pathogens. ICU, intensive-care unit. Clinical Microbiology and Infection 2013 19, 10-14DOI: (10.1111/1469-0691.12024) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions